Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
10.79
+0.03 (0.28%)
At close: May 16, 2025, 4:00 PM
10.62
-0.17 (-1.58%)
After-hours: May 16, 2025, 7:51 PM EDT
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $7.70 billion as of May 16, 2025. Its market cap has decreased by -14.77% in one year.
Market Cap
7.70B
Enterprise Value
2.65B
1-Year Change
-14.77%
Ranking
Category
Stock Price
$10.79
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $7.70B, an increase of 1,343.48%. That is a compound annual growth rate of 82.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 7.70B | -10.60% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | 521.58M | -2.21% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 658.30B |
| Johnson & Johnson | 359.97B |
| AbbVie | 320.92B |
| Novo Nordisk | 289.00B |
| UnitedHealth Group | 248.87B |
| Abbott Laboratories | 232.01B |
| Novartis AG | 211.47B |
| AstraZeneca | 208.86B |